AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING (Q2043834)

From EU Knowledge Graph
Revision as of 08:41, 2 November 2020 by DG Regio (talk | contribs) (‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Jump to navigation Jump to search
Project Q2043834 in Italy
Language Label Description Also known as
English
AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING
Project Q2043834 in Italy

    Statements

    country
    Italy
    0 references
    EU contribution
    15,000.0 Euro
    0 references
    budget
    30,000.0 Euro
    0 references
    co-financing rate
    50.0 percent
    0 references
    start time
    25 October 2017
    0 references
    end time
    15 October 2018
    0 references
    expected end time
    30 December 2019
    0 references
    beneficiary name (string)
    ARDIS S.R.L.
    0 references
    beneficiary
    Q286010
    0 references
    coordinate location

    45°11'9.60"N, 9°9'16.70"E
    0 references
    summary
    AN INNOVATIVE TECHNOLOGY PLATFORM FOR THE DEVELOPMENT AND COMMERCIALISATION OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY PRE-TREATMENT DIAGNOSTIC TESTING (Italian)
    0 references
    AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING (English)
    0 references

    Identifiers

    Italian Unique Project Code
    E17F17000030002
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2043834&oldid=7646398"